Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,6 USD | -2,14% | +17,65% | -48,72% |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 17,64 mln. 16,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -17 mln. -15,79 mln. | Nettowinst (verlies) 2023 | -10 mln. -9,29 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 13,25 mln. 12,3 mln. | Nettoliquiditeiten 2023 | 3,84 mln. 3,57 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,65
x | K/w-verhouding 2023 |
-1,53
x | Werknemers | 11 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 28,78% |
Recentste transcriptie over Akari Therapeutics, Plc
1 dag | -2,14% | ||
1 week | +8,84% | ||
Lopende maand | +3,90% | ||
1 maand | +21,67% | ||
3 maanden | -33,33% | ||
6 maanden | -54,35% | ||
Lopend jaar | -48,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 79 | 01-09-15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19-07-23 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01-06-16 |
Founder | 79 | 01-09-15 | |
Director/Board Member | 61 | 05-07-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 1,6 | -2,14% | 19 063 |
09-05-24 | 1,635 | +12,76% | 30 367 |
08-05-24 | 1,45 | 0,00% | 11 683 |
07-05-24 | 1,45 | +8,21% | 12 419 |
06-05-24 | 1,34 | -1,47% | 16 327 |
uitgestelde koers Nasdaq, 10 mei 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-48,72% | 12,96 mln. | |
+3,91% | 108 mld. | |
+10,87% | 104 mld. | |
+1,28% | 22,33 mld. | |
-13,14% | 22,19 mld. | |
-7,05% | 18,69 mld. | |
-38,36% | 17,74 mld. | |
-10,66% | 17,64 mld. | |
+3,75% | 14,05 mld. | |
+36,70% | 12,51 mld. |